SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328700. A total of 52 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $121,000 | +49.4% | 99,441 | -49.1% | 0.01% | +20.0% |
| Q4 2018 | $81,000 | -79.3% | 195,474 | 0.0% | 0.01% | -74.4% |
| Q3 2018 | $391,000 | -5.6% | 195,474 | 0.0% | 0.04% | -26.4% |
| Q2 2018 | $414,000 | -22.2% | 195,474 | 0.0% | 0.05% | -29.3% |
| Q1 2018 | $532,000 | -71.2% | 195,474 | -60.9% | 0.08% | -81.0% |
| Q4 2017 | $1,845,000 | +90.2% | 500,000 | 0.0% | 0.40% | +101.5% |
| Q3 2017 | $970,000 | -28.1% | 500,000 | 0.0% | 0.20% | -42.4% |
| Q2 2017 | $1,350,000 | -34.1% | 500,000 | 0.0% | 0.34% | -43.6% |
| Q1 2017 | $2,050,000 | +13.3% | 500,000 | 0.0% | 0.60% | +1.2% |
| Q4 2016 | $1,810,000 | – | 500,000 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|